We initiate coverage on Goodbody Health Group with a buy rating and 10p price target. Goodbody is a holistic wellness company embarking on an exciting period of growth. It has recently diversified and repositioned its strategy to deepen its clinical offering and take advantage of the long-term structural themes driving customer attitudes to health and wellbeing - which we believe the market is yet to give it value for. With a 40% ROE, Revenue 20A-23E CAGR of 210%, EBITDA 21-23E CAGR of >300% and ....
19 Jan 2022
Goodbody Health* - Initiating with Buy, 10p PT; Time to move the needle
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Goodbody Health* - Initiating with Buy, 10p PT; Time to move the needle
- Published:
19 Jan 2022 -
Author:
Andrew Simms | Philip Modu -
Pages:
49
We initiate coverage on Goodbody Health Group with a buy rating and 10p price target. Goodbody is a holistic wellness company embarking on an exciting period of growth. It has recently diversified and repositioned its strategy to deepen its clinical offering and take advantage of the long-term structural themes driving customer attitudes to health and wellbeing - which we believe the market is yet to give it value for. With a 40% ROE, Revenue 20A-23E CAGR of 210%, EBITDA 21-23E CAGR of >300% and ....